baber/WOPTO huggingface dataset:
Patent NZ-545221-A (NZ)
Title: Crystalline tumor necrosis factor receptor 2 polypeptides
Inventor: OSSLUND TIMOTHY D
IPC: G06F19/00
Filed: 2004-07-29
Abstract: Disclosed is a crystal of etanercept and a method of making said crystal.
Patent NZ-549660-A (NZ)
Title: Electrical appliance wall mounting including support means and electricity supply means
Inventor: GWATKIN DOUGLAS JOHN
Filed: 2006-09-01
Abstract: A wall mounting that provides both mechanical support and electrical connection for an electric appliance is disclosed. A wall mounting plate has a rear side for mounting against a surface, and a front side with first engagement means and first electrical terminals. The appliance has a rear side with second engagement means which is complementary to the first engagement means. The appliance can be engaged with the wall mounting plate by sequentially aligning the rear side of the appliance to face the front side of the wall mounting plate, moving the appliance toward the plate to bring together the engagement means, and sliding the appliance relative to the wall mounting plate thereby engaging the first and second engagement means. An electrical connection between the first and second electrical terminals is made so that electricity can be provided to operate the appliance when it is held in a supportive engagement on the wall mounting plate.
Patent NZ-552293-A (NZ)
Title: Tablet formulation comprising a macrocyclic lactone and a levamisole compound having anthelmintic activity
Inventor: AL ALAWI FADIL
Filed: 2006-12-21
Abstract: Disclosed is a tablet formulated for administration to an animal characterised in that the tablet includes: (a) at least one macrocyclic lactone compound having anthelmintic activity and; (b) at least one levamisole compound having anthelmintic activity and; wherein the macrocyclic lactone compound or compounds have been dissolved in at least one organic solvent and then subsequently mixed with at least one co-solvent prior to tablet formation.
Patent NZ-553057-A (NZ)
Title: Method and device for diagnosing and treating insulin-like growth factor deficiency disorders
Inventor: CLARK ROSS G
IPC: G01N33/00
Filed: 2005-08-29
Abstract: A diagnostic system for diagnosing an insulin-like growth factor-1 deficiency (IGFD) in a subject comprises a central computing environment; an input device, operatively connected to the computing environment, to receive patient data, an output device, operatively connected to the computing environment, to provide information to a user; and a computer program executed by the central computing environment. The computer program is executed based on the data received by the input device. A portable apparatus for diagnosing an insulin-like growth factor-1 deficiency (lGFD) in a patient comprises a means for receiving and storing patient data; a data output means and a computer program stored within the apparatus. The patient data include age, insulin-like growth factor-1 (IGF-1) blood concentration, and insulin-like growth factor binding protein-3 (IGFBP-3) blood concentration. The computer program transforms the IGF-1 blood concentration (IGF-1 blood conc) into an IGF-1 clearance rate based on the IGFBP-3 blood concentration and the computer program transforms the IGF-1 clearance rate into an IGF-1 production rate by the formula: IGF-1 production rate = (IGF-1 bloodconc)(IGF-1 clearance rate).
Patent NZ-555770-A (NZ)
Title: Heterocyclic piperazine-carboxamide compounds as CCR2B antagonists
Inventor: BOWER JUSTIN FAIRFIELD
IPC: A61K31/497
Filed: 2005-12-19
Abstract: Piperazin-carbonyl-piperazine-carboxamide derivatives of formula (Ia) and pharmaceutically acceptable salts or solvates thereof are disclosed, wherein the variables are as defined in the specification. These compounds are useful in the treatment of C-C chemokine mediated conditions selected from asthma, allergic rhinitis, COPO, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, and psoriasis.
Patent NZ-556634-A (NZ)
Title: First and second spaced apart core elements placed around conduit in closed loop pumped water supply system with radio frequency magnetic fluxes generated
Inventor: STEFANINI DANIEL
IPC: C02F1/00
Filed: 2005-12-20
Abstract: First and second core elements of magnetically conductive material are mounted to the conduit at spaced positions, with the conduit being part of a pumped closed loop of a water supply system. Means is provided for establishing radio frequency magnetic fluxes in said core elements, for generating respective electromagnetic fields in the fluid to be treated extending from spaced positions along the conduit.
Patent NZ-562520-A (NZ)
Title: Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
Inventor: DAVIDSON ALAN HORNSBY
IPC: C07D215/233
Filed: 2006-05-04
Abstract: Disclosed is a quinoline or quinazoline derivative of formula (IA) or (IB), or a salt, N-oxide, hydrate, or solvate thereof, wherein the substituents are as defined in the specification. Also disclosed is the use of the compound for treating a cell-proliferation or autoimmune disease, such as cancer.
Patent NZ-564025-A (NZ)
Title: Reduced risk tobacco products and methods of making same
Inventor: ALBINO ANTHONY
IPC: A24F47/00
Filed: 2006-05-10
Abstract: Provided is a method of selecting a tobacco having a reduced health risk potential of a tobacco comprising: (a) providing a tobacco; (b) obtaining whole smoke from said tobacco, wherein said whole smoke is obtained from a cigarette after passing through a filter attached to said cigarette.; (c) contacting an isolated human cell with said whole smoke obtained from said tobacco; (d) identifying a tobacco-induced change in cell homeostasis, gene expression, or protein expression in said isolated human cell contacted with said smoke; and (e) selecting a tobacco having a lower health risk potential compared to a reference tobacco based on the identified change in cell homeostasis, gene expression, or protein expression of step (d).
Patent NZ-565420-A (NZ)
Title: Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist, namely a IL-10 or IL-10R antibody, and a TLR-9 agonist
Inventor: VICARI ALAIN P
IPC: C12N5/08
Filed: 2002-11-26
Abstract: Disclosed in the use of a tumor-derived dendritic cell (DC) inhibitory factor antagonist in combination with a TLR-9 agonist in the manufacture of a medicament for treating cancer, wherein the tumor-derived OC inhibitory factor is an IL-10 or IL-1 OR antibody or functional fragment thereof.
Patent NZ-575328-A (NZ)
Title: Cell culture improvements
Inventor: PLA ITZCOATL A
IPC: C12N5/00
Filed: 2007-09-13
Abstract: Provided is a fed batch method of producing a protein comprising a) culturing mammalian cells comprising a nucleic acid encoding the protein in a cell culture comprising a cell culture production medium; and b) feeding the mammalian cells by adding a hydrolysate enrichment solution and a basal enrichment solution to the cell culture during a time period, wherein the hydrolysate enrichment solution comprises a plant-based hydrolysate and 75-300 g/L of a yeast-based hydrolysate, such that the protein is produced. The method can be used to produce antibodies, e.g. TNF-alpha antibodies in Chinese Hamster Ovary (CHO) cells.
Patent NZ-579560-A (NZ)
Title: Infant monitor
Inventor: GALLAGHER GREGORY JOHN
IPC: G16H40/63
Filed: 2008-02-08
Abstract: Disclosed is a device for monitoring regular movement of the body of a human subject such as an infant, said device comprising: electronic circuitry including at least one alarm; and attachment means for releasably attaching the device to the subject's body; characterised in that said device includes a resiliently flexible protuberance extending from the device; and a transducer connected to the electronic circuitry and being configured to detect deflection of the protuberance; said attachment means and protuberance being configured such that the protuberance abuts the body of the subject when the device is attached to the subject's body and said circuitry being configured to activate the alarm in the event that a pattern of the detected deflection of the protuberance changes to a predetermined extent. Also disclosed is a method of monitoring regular movement of the body of a human subject such as an infant, said method including: releasably attaching a monitoring device to the subject's body, with a protuberance of the device in abutting contact with the body of the subject; characterised by allowing regular movement of the subject's body relative to the monitoring device to be transferred to the protuberance, causing the protuberance to deflect; and activating an alarm if the pattern of deflection of the protuberance changes to a predetermined extent.
Patent NZ-580117-A (NZ)
Title: Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
Inventor: NAKAZATO ATSURO
IPC: C07F9/00
Filed: 2005-06-24
Abstract: Disclosed is a pyrrolopyrimide or pyrrolopyridine derivative of formula [I], wherein X is -CON(R10)R11, Y is N or CR15, m is 0-5, n is 0-1 and m+n is 1-5, and wherein the other substituents are as defined in the specification. Also disclosed is the use of the above compound as an antagonist for CRF receptors. (62) Divided Out of 551427
Patent NZ-580607-A (NZ)
Title: Binding molecules capable of neutralizing rabies virus and uses thereof
Inventor: BAKKER ALEXANDER BERTHOLD HENDRIK
IPC: G01N33/569
Filed: 2005-05-26
Abstract: Provided is a method of identifying a binding molecule potentially having neutralizing activity against a rabies virus or a nucleic acid molecule encoding a binding molecule potentially having neutralizing activity against a rabies virus, wherein the method comprises the steps of: a) contacting a collection of binding molecules on the surface of replicable genetic packages with a cell transfected with and expressing recombinant G protein of a rabies virus under conditions conducive to binding, wherein the collection of binding molecules is prepared from RNA isolated from cells obtained from a subject that has been vaccinated against rabies or that has been exposed to rabies virus. b) separating and recovering binding molecules that bind to the rabies virus from binding molecules that do not bind, c) isolating at least one recovered binding molecule, d) verifying if the binding molecule isolated has neutralizing activity against rabies virus. (62) Divided Out of 550366
Patent NZ-582946-A (NZ)
Title: Natural stabiliser system for frozen dessert
Inventor: QUESSETTE MAYLIS
IPC: A23G9/32
Filed: 2008-07-03
Abstract: Disclosed herein is a stabiliser system of natural ingredients for use in frozen confectionery comprising native rice starch, egg yolk as a natural emulsifier and citrus fibres. Also discloses are methods for the manufacture of frozen confectionery using said stabiliser system.
Patent NZ-583532-A (NZ)
Title: Cellulases, nucleic acids encoding them and methods for making and using them
Inventor: BLUM DAVID
IPC: C07H21/04
Filed: 2006-01-13
Abstract: Provided is an isolated or recombinant nucleic acid comprising (a) a nucleic acid sequence having at least 70% or more sequence identity to a specified nucleotide sequence, wherein the nucleic acid encodes at least one polypeptide having a cellulose activity, or an enzymatically active fragment thereof, (b) a nucleic acid sequence that hybridizes under stringent conditions to a complement of the nucleic acid, wherein the nucleic acid encodes a polypeptide having a cellulase activity, or an enzymatically active fragment thereof , and the stringent conditions include a wash step comprising a wash in 0.2X SSC at a temperature of about 65°C for about 15 minutes, (c) a nucleic acid sequence encoding a polypeptide having a corresponding polypeptide sequence, or enzymatically active fragments thereof; or (d) a nucleic acid sequence complementary to (a), (b) or (c). Further provided are various methods of utilizing the sequences.
Patent NZ-583693-A (NZ)
Title: Fastening tool for driving fastening elements of different lengths
Inventor: HERELIER PATRICK
IPC: B25C1/08
Filed: 2008-09-03
Abstract: A fastening tool is disclosed for driving fastening elements (11) of different lengths. The tool comprises an assembly of a tip-guide and a shear unit (40) to which can be fastened a charger comprising fastening elements (11). The fastening elements (11) are introduced from the charger into a bore (12) of the tip-guide through a passing window (13) provided inside the shear unit (40). The tool comprises an adjustment device (51) for adjusting the effective length of the passing window (13) to the length of the fastening elements (11) to be driven and which is submitted to return means in a partial plugging position of the window (13) for the shortest fastening element. The adjustment device comprises a flap (51) pivotally mounted about an axis (61) substantially parallel to the bore (12) of the tip-guide and is adapted to provide a guiding surface (59) for the shortest fastening elements before they enter into the partially plugged passing window (13).
Patent NZ-590266-A (NZ)
Title: Protein kinase inhibitors based on dihydro-5h-pyrimido[4,5-b]diazepin or dihydropteridin
Inventor: CHARRIER JEAN-DAMIEN
IPC: A61K31/4985
Filed: 2009-06-23
Abstract: Disclosed is a dihydro-5H-pyrimido[4,5-b]diazepin or dihydroteridin compound of formula (I) where the substituents are as disclosed in the description and examples of compounds are: 9-cyclopentyl-5,7,7-trimethyl-2-(1-phenylethylamino)-8,9-dihydro-5Hpyrimido[4,5-b] [1 ,4]diazepin-6(7H)-one; 9-cyclopentyl-5,7,7 -trimethyl-2-(1-phenylpropylamino)-8,9-dihydro-5H-pyrimido[4,5-b] [1,4]diazepin-6(7H)-one; 5-cyclopentyl-4-ethyl-N-(1-phenylethyl)-4,5-dihydro-[1,2,4 ]triazolo[4,3-f]pteridin-7-N-(1-(4-bromophenyl)ethyl)-5-cyclopentyl-4-ethyl-4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridin-7-amine and 5-cyclopentyl-4-ethyl-N-(1-(4-(4-methylpiperazin-1-yl)phenyl)ethyl)-4,5-dihydro[1,2,4]triazolo[4,3-f]pteridin-7-amine. Also disclosed is a composition comprising a compound of formula (I) and the use of the compound in the manufacture of a medicament for inhibiting protein kinase (PLK or PLK1) for treating a proliferative disorder, a neurodegenerative disorder, an autoimmune disorder, an inflammatory disorder, or an immunologically mediated disorder in a patient in need thereof. For example melanoma, myeloma, leukaemia, lymphoma, neuroblastoma, colon cancer, breast cancer, gastric cancer, ovarian cancer, cervical cancer, lung cancer, central nervous system cancer, renal cancer, prostate cancer, bladder cancer, or pancreatic cancer.
Patent NZ-592840-A (NZ)
Title: Multi-stage nutrigenomic diagnostic food sensitivity testing in animals
Inventor: DODDS W
IPC: G01N33/02
Filed: 2010-01-11
Abstract: Provided is a method for diagnosing a food sensitivity in a companion animal comprising the steps of screening a sample of saliva from a companion animal to detect the level of IgA antibody and IgM antibody to a particular food ingredient or composition, and diagnosing a food sensitivity of the companion animal based on the presence of at least one of the antibodies. The animal can be a cat, rabbit, hamster or horse.
Patent NZ-598417-A (NZ)
Title: Modifying glycoprotein production in plants
Inventor: MARC-ANDRE D AOUST
IPC: C12N5/10
Filed: 2008-06-13
Abstract: 598417 Modifying glycoprotein production in plants Provided is a method for synthesizing a protein of interest with reduced fucosylation and xylosylation comprising, introducing within a plant, a portion of a plant, or a plant cell, a nucleotide sequence encoding a first nucleotide sequence encoding beta-1,4-galactosyltransferase (GalT), the first nucleotide sequence operatively linked with a first regulatory region that is active in the plant, and a second nucleotide sequence for encoding the protein of interest, the second nucleotide sequence operatively linked with a second regulatory region that is active in the plant, and transiently co-expressing the first and second nucleotide sequences to synthesize the protein of interest comprising reduced fucosylation and xylosylation.
Patent NZ-599816-A (NZ)
Title: An apparatus for generating heat
Inventor: COLLINS MARK
IPC: F24V30/00
Filed: 2010-10-07
Abstract: Disclosed is an apparatus for heating a liquid. The apparatus has a mixing chamber (8) and dispensing means for dispensing metered amounts of first and second chemical reactants into the mixing chamber (8) to form a reaction mixture so that the chemical reactants undergo an exothermic chemical reaction to generate heat and one or more reaction products. An electronic control device (30) is linked to the dispensing means and controls the dispensing of the metered amounts of first and second chemical reactants. One or more pumps move the chemical reactants and reaction mixture around the apparatus. A heat exchanger (6) has an inlet and an outlet for the reaction mixture and an inlet and an outlet for the liquid, so that when the liquid passes through the heat exchanger it is heated by heat transfer from the reaction mixture. One or more monitoring stations (12) monitor one or more physical or chemical parameters of the reaction mixture and communicate with the electronic control device (30) and a waste outlet (68) removes spent reaction mixture from the apparatus. The mixing chamber (8), heat exchanger (6) and the one or more monitoring stations (12) are connected so as to form a loop. The electronic control device (30) is programmed to cause the reaction mixture to be circulated around the loop at least twice, and optionally to cause the dispensing means to dispense further metered amounts of first and/or second chemical reactants into the mixing chamber; and/or to cause a proportion of the reaction mixture to be ejected through the waste outlet (68), in order to control the temperature of the reaction mixture passing through the heat exchanger (6).
Patent NZ-601701-A (NZ)
Title: Controller, image forming apparatus, customizing method, and program
Inventor: KATSUMATA MOTOYUKI
IPC: G06F3/048
Filed: 2011-03-01
Abstract: A method of customizing an arrangement on an operation screen of one or more function-setting components and the controller thereof are disclosed. The controller has a display apparatus (100) for displaying an operation screen with one or more function-setting components being arranged on the operation screen. The function-setting components have setting information of a function of application software arranged thereon. The controller comprises a layout specifying information storage unit for storing layout specifying information specifying a layout of the one or more function-setting components on the operation screen; a display information storage unit for storing display mode information defining a display mode of the setting information and the setting information for each function; a function list display unit for displaying a list of functions for each application software; a screen generating unit for accepting a selection of a function from the list and generating a function-setting component list screen displaying in a list the function-setting component of the function; and an arrangement determining unit for determining an arrangement on the operation screen of a function-setting component to be arranged. The function-setting component to be arranged is configured to be selected from the function setting component list screen. The arrangement determining unit updates the layout specifying information with a layout and the function-setting component to be arranged are arranged in the layout.
Patent NZ-603616-A (NZ)
Title: Apparatus and process of purification of proteins
Inventor: WANG CHEN
IPC: C07K1/36
Filed: 2011-04-13
Abstract: Disclosed is an apparatus for purifying a protein from a sample containing the protein to be purified, comprising: a. a capture chromatography resin; b. a depth filter arranged with respect to the capture chromatography resin so that the sample processes through the capture chromatography resin to and through the depth filter; and c. a mixed-mode chromatography resin arranged with respect to the depth filter so that the sample processes through the depth filter to and through the mixed-mode chromatography resin.
Patent NZ-606552-A (NZ)
Title: High pressure recovery of carbon dioxide from a fermentation process
Inventor: FIND RASMUS
IPC: C01B32/50
Filed: 2011-07-01
Abstract: 606552 Disclosed herein is a method for recovering carbon dioxide from a gaseous stream originating from a fermentation process by compression, absorption, condensation and distillation, wherein at least the absorption and condensation is performed under a high pressure of at least 30 bar. The method is additionally disclosed as comprising compression, absorption, condensation, and distillation steps.
Patent NZ-608206-A (NZ)
Title: Antibodies that bind myostatin, compositions and methods
Inventor: HAN HQ
IPC: A61K39/00
Filed: 2011-08-15
Abstract: Disclosed is an isolated myostatin-specific antibody comprising at least one light chain and at least one heavy chain, wherein the light chain comprises a constant region and a variable region that comprises three complementarity determining regions (CDRs) and the heavy chain comprises a constant region and a variable region that comprises three CDRs, wherein the light chain CDR1, CDR2 and CDR3 are KASQDINKYVA, YTSWLQP and LQYDNLLYT, respectively, and the heavy chain CDR1, CDR2 and CDR3 are RYWMN, XIRLKSDNYATHYAESVKG and GLDY, respectively. Also disclosed is the use of the above-described myostatin-specific antibody in the preparation of a medicament for treatment or prevention of a disease or condition associated with activity of myostatin.
Patent NZ-613626-A (NZ)
Title: Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
Inventor: ANAND RAJAN
IPC: C07D471/04
Filed: 2012-02-23
Abstract: Disclosed herein are imidazo[4,5-b]pyridine derivatives of formula (I) and pharmaceutically acceptable salts thereof, wherein T is N; U is CR1; V is CR2; W is CR4; X is -O- or –O-CH2, and the other variables shown in formula (I) are as defined in the specification. These imidazo[4,5-b]pyridine derivatives are suitable for the treatment of a disorder, condition, or disease selected from the group consisting of: Type 2 diabetes, hyperglycemia, Metabolic Syndrome, obesity, hypercholesterolemia, and hypertension, in a mammal in need thereof.
Patent NZ-615342-A (NZ)
Title: Hydraulic turbine and hydroelectric power plant
Inventor: JOKELA JOUNI
IPC: F03B17/06
Filed: 2012-04-27
Abstract: A turbine (17) for hydraulic power generation using a low or very low hydraulic head includes two bladed wheels (31, 32) successively arranged in a turbine tube section (21) the inside diameter of which increases in the direction of water flow through the tube. A fore wheel (31) and after wheel (32) are arranged with respect to a water flow direction (23) along a common rotation axis (30) extending in the direction of the water flow direction (23). The wheels (31, 32) rotate in opposite directions and are driven by the water flow. A first gear (46) and a second gear (47) are arranged along the rotation axis (30). The first gear (46) is connected to the fore wheel (31) and the second gear (47) is connected to the after wheel (32) such that the first (46) and second (47) gears are configured to rotate around the rotation axis (30) driven by each respective wheel (31, 32). The first (46) and second (47) gears are connected via an engagement gearing (48). The fore (31) and after (32) wheels are coupled to each other with respect to their rotation speed. The engagement gearing (48) is connectable to a power generator (51).